Results, Reports and Publications
Latest Results
Clariant delivers third year of strong EBITDA margin improvement – EBITDA margin before exceptional items up 180 basis points versus prior year to 17.8 %
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
- Q4 2025 sales increased by 1 % in local currencies1 to CHF 1.028 billion due to strong volume growth in Catalysts and Care Chemicals
- Q4 2025 EBITDA margin before exceptional items increased by 240 basis points to 17.1 %, with strong profitability improvement in Catalysts and Care Chemicals
- FY 2025 sales of CHF 3.915 billion flat in local currencies1 including 1 % scope (Lucas Meyer Cosmetics)
- FY 2025 EBITDA margin before exceptional items increased by 180 basis points to 17.8 %, driven by performance improvement programs and cost productivity across the entire organization
- Performance improvement program achieved CHF 50 million savings in 2025, on track to deliver CHF 80 million with the remainder largely expected in 2026
- FY 2025 free cash flow conversion of 42 % increased by 10 percentage points, already achieving the medium-term target level
- Stable distribution of CHF 0.42 per share to be proposed to AGM on 1 April 2026
- Outlook 2026: local currency sales to be around flat; EBITDA margin before exceptional items at around 18 %; medium-term targets confirmed
“In 2025, Clariant delivered an EBITDA margin of 17.8 % before exceptional items, a significant year-on-year increase of 180 basis points. This represents the third consecutive year of EBITDA improvement, both in absolute and margin terms. We achieved this through our performance improvement programs, effective price management, and cost productivity. We made substantial progress in all pillars of our purpose-led growth strategy, including our non-financial and sustainability targets in 2025. With strong execution of our commercial excellence programs, our customer Net Promoter Score (cNPS) increased to 50, placing Clariant in the top quartile among peers. We accelerated the rollout of CLARITY™, our digital service platform designed to optimize catalyst management and performance monitoring, almost doubling the number of users to over 800 in 38 countries. We achieved growth in innovation sales, reaching 18.8 %, reflecting the strength of Clariant's innovation pipeline. Our focus on safety resulted in a Days Away, Restricted, or Transferred (DART) rate of 0.13, significantly down from 2024 and placing Clariant in the top quartile of the chemical industry,” said Conrad Keijzer, Chief Executive Officer of Clariant. “For 2026, we expect sales in local currency to be around flat in a continued challenging market environment, while in addition we offset our portfolio pruning in the prior year. We expect an EBITDA margin of around 18 % before exceptional items,” Conrad Keijzer added.
1 All references to local currency growth, pricing, volumes, and scope exclude the impact from hyperinflation countries Argentina and Türkiye. All references to currency include a net impact from hyperinflation countries Argentina and Türkiye.
Results Center
Please use the Results Center to find Clariant’s financial results and associated documents as published in the last five years
Q1 Q2 Q3 Q4 Date 29 April 2025 31 July 2025 30 October 2025 26 February 2026 Quiet Period as of 10 April as of 9 July as of 8 October as of 19 January 2026 Media Release EN EN EN EN Analyst Presentation EN EN EN EN Webcast Replay Audio recording MP3 MP3 MP3 MP3 Transcript EN EN EN Financial Review / HY Report EN - XLS EN - XLS Annual Report
Q1 Q2 Q3 Q4 Date 30 April 2024 30 July 2024 29 October 2024 28 February 2025 Quiet Period as of 11 April as of 10 July as of 9 October as of 10 January 2025 Media Release EN EN EN EN Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript EN EN EN EN Financial Review / HY Report EN - XLS EN - XLS Annual Report EN
Q1 Q2 Q3 Q4 Date 5 May 2023 28 July 2023 30 October 2023 29 February 2024 Quiet Period as of 17 April as of 10 July as of 10 October as of 15 January Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript EN EN EN EN Financial Review / HY Report EN EN — XLS Annual Report EN
Q1 Q2 Q3 Q4 Date 15 June 2022 28 July 2022 27 October 2022 2 March 2023 Quiet Period as of 11 July as of 10 October as of 17 February Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript
EN Financial Review / HY Report EN EN Annual Report EN
Q1 Q2 Q3 Q4 Date 29 April 2021 29 July 2021 28 October 2021 19 May 2022 Quiet Period as of 19 April as of 12 July as of 18 October Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript
Financial Review / HY Report EN EN Annual Report EN
Conferences and Roadshows
Clariant's Management and Investor Relations Team regularly participates in Conferences and Roadshows. Below you can find an overview of the presentations provided at such events in the last two years.
For an overview of upcoming events, please refer to the Financial Calendar.
